Indeed, adding the programmed cell death protein 1 (PD-1)/programmed death-ligand (PD-L1) pathway blockers prevent tumor cells from evading the immune system by blocking PD-1/PD-L1-mediated immune cell suppression (38). This evidence concerns the gene PDCD1 and neoplasm.